Brand-NameDrugHealthEconomicsand OutcomesResearch(HEOR)CopayMail-OrderPharmacyAdherenceOut-of-PocketCostReal-WorldEvidenceGenericDrugValue-BasedCareBiosimilarNetworkPharmacyHealthPlanNon-PreferredDrugPharmacyBenefitPipelineDrugSpecialtyDrugStepTherapyClinicalTrialPharmacyBenefitManager(PBM)FormularyMedicalBenefitIndicationUtilizationManagementP&TCommitteeRebateFDAApprovalPreferredDrugCostSharingPriorAuthorizationClaimsDataTieredFormularyMarketAccessBrand-NameDrugHealthEconomicsand OutcomesResearch(HEOR)CopayMail-OrderPharmacyAdherenceOut-of-PocketCostReal-WorldEvidenceGenericDrugValue-BasedCareBiosimilarNetworkPharmacyHealthPlanNon-PreferredDrugPharmacyBenefitPipelineDrugSpecialtyDrugStepTherapyClinicalTrialPharmacyBenefitManager(PBM)FormularyMedicalBenefitIndicationUtilizationManagementP&TCommitteeRebateFDAApprovalPreferredDrugCostSharingPriorAuthorizationClaimsDataTieredFormularyMarketAccess

GBM 1: Managed Care Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
  1. Brand-Name Drug
  2. Health Economics and Outcomes Research (HEOR)
  3. Copay
  4. Mail-Order Pharmacy
  5. Adherence
  6. Out-of-Pocket Cost
  7. Real-World Evidence
  8. Generic Drug
  9. Value-Based Care
  10. Biosimilar
  11. Network Pharmacy
  12. Health Plan
  13. Non-Preferred Drug
  14. Pharmacy Benefit
  15. Pipeline Drug
  16. Specialty Drug
  17. Step Therapy
  18. Clinical Trial
  19. Pharmacy Benefit Manager (PBM)
  20. Formulary
  21. Medical Benefit
  22. Indication
  23. Utilization Management
  24. P&T Committee
  25. Rebate
  26. FDA Approval
  27. Preferred Drug
  28. Cost Sharing
  29. Prior Authorization
  30. Claims Data
  31. Tiered Formulary
  32. Market Access